Engineering Src family protein kinases with unnatural nucleotide specificity

Chemistry and Biology

Volumn 5, Issue 2, 1998, Pages 91-101

  Liu, Yi ^a   Shah, Kavita ^a   Yang, Feng ^a   Witucki, Laurie ^a   Shokat, Kevan M ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

ATP analog; Protein engineering; Protein phosphorylation; Src protein kinase

Indexed keywords

EID: 0032008085     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90143-0     Document Type: Article

References (42)

1. Hunter, T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
2. Brugge, J.S. & Erikson, R.L. (1977). Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature 269, 346-348.
3. Jove, R. & Hanafusa, H. (1987). Cell transformation by the viral Src oncogene. Ann. Rev. Cell Biol. 3, 31 -56.
4. Cohen, G.B., Ren, R. & Baltimore, D. (1995). Modular binding domains in signal transduction proteins. Cell 80, 237-248.
5. Erpel, T. & Courtneidge, S.A. (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7, 176-182.
6. Pawson, T. (1995). Protein modules and signaling networks. Nature 373, 573-580.
7. Yu, H., Rosen, M.K., Shin, T.B., Seidel-Dugan, C., Brugge, J.S. & Schreiber, S.L. (1992). Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 258, 1665-1668.
8. Waksman, G., et al., & Kuriyan, J. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-Src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
9. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan, J. (1993). Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 779-790.
10. Bishop, J. (1985). Viral oncogenes. Cell 42, 23-28.
11. Xu, W., Harrison, S.C. & Eck, M.J. (1997). Three dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
12. Kato, J.-Y., Takeya, T., Gandori, C., Iba, N., Levy, J.B. & Hanafusa, H. (1986). Amino-acid substitutions sufficient to convert the nontransforming p60c-Src protein to a transforming protein. Mol. Cell. Biol. 6, 4155-4160.
13. Kamps, M.P. & Sefton, B.M. (1988). Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinase in normal cells. Oncogene Res. 3, 105-115.
14. Brown, M.T. & Cooper, J.A. (1996). Regulation, substrates and functions of src. Biochim Biophys Acta 1287, 121-149.
15. Hunter, T. (1987). A thousand and one protein kinases. Cell 50, 823-829.
16. Songyang, Z., Carraway, K.L.I, et al. & (1995). Catalytic specificity of protein tyrosine kinases is critical for selective signalling. Nature 373, 536-539.
17. Hunter, T. & Sefton, B.M. (1980). Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl Acad. Sci. USA 77, 1311-1315.
18. Shah, K., Liu, Y., Deirmengian, C. & Shokat, K.M. (1997). Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc. Natl Acad. Sci. USA 94, 3565-3570.
19. Hubbard, S.R., Wei, L., Ellis, L. & Hendrickson, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
20. Mohammadi, M., Schlessinger, J. & Hubbard, S.R. (1996). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-587.
21. Zheng, J., et al., & Sowadski, J.M. (1993). Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry 32, 2154-2161.
22. Jeffrey, P.D., Russo, A.A. et al., & Pauletich, N.P. (1995). Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320.
23. Sicheri, F., Moarefi, I. & Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
24. Yamaguchi, H. & Hendrickson, W.A. (1996). Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384, 484-489.
25. Cleland, J.L. & Craik, C.S. (1996). Protein Engineering: Principles and Practice. Wiley-Liss.
26. Van, B.X. & Sun, Y.Q. (1997). Glycine Residues provide flexibility for enzyme active sites. J. Biol. Chem. 272, 3190-3194.
27. Barker, S.C., Kassel, D.B., Weigl, D., Huang, X., Luther, MA & Knight, W.B. (1995). Characterization of pp60c-Src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry 34, 14843-14851.
28. Bishop, A.C., Shah, K., Liu, Y., Witueki, L, Kung, C.-Y. & Shokat, K.M. (1998). Design of allele-specific inhibitors to probe protein kinase signalling. Curr. Biol. 8, 257-266.
29. Ingraham, C.A., Cooke, M.P., Chuang, Y.N., Perlmutter, R.M. & Maness, P.F. (1992). Cell type and developmental regulation of the Fyn proto-oncogene in neutal retina. Oncogene 7, 95-100.
30. Page, S.T., Van Oeres, N.S.C., Perlmutter, R.M., Weiss, A. & Pullen, A.M. (1997). Differential contribution of Lck and Fyn protein tyrosine kinase to intraepithelial lymphocyte development. Eur. J. Immunol 27, 554-562.
31. Cooke, M.P., Abraham, K.M., Forbush, K.K. & Perlmutter, R.M. (1991). Regulation of T cell receptor signalling by a Src family protein tyrosine kinase (p59Fyn). Cell 65, 281-291.
32. Lansing, T.J., Turk, B.F., Kanner, S.B. & Gilmer, T.M. (1997). Mutational activation of pp60c-Src leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line. Cancer Res. 57, 1962-1969.
33. Cooke, M.P. & Perlmutter, R.M. (1989). Expression of a novel form of the Fyn proto-oncogene in hematopoietic cells. New Biol. 1, 66-74.
34. Scott, J.D., Glaccum, M.B., Fischer, E.H. & Krebs, E.G. (1996). Primary structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 83, 1613-1616.
35. Fields, C.G., Fields, G.B., Noble, R.L. & Cross, T.A. (1989). Solidphase peptide synthesis of 15N-gramicidins A, B and C and high performance liquids Chromatographic purification. Int. J. Pept. Protein Res. 33, 298-303.
36. King, D.S., Fields, C.G. & Fields, G.B. (1990). A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 36, 255-266.
37. Reikofski, J. & Tao, B.Y. (1992). PCR techniques for site-directed mutagenesis. Biotechnol Adv. 10, 535-554.
38. Xu, B., Bird, G.V. & Miller, T.W. (1995). Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains. J. Biol. Chem. 270, 29825-29830.
39. Lee, T.R., Niu, J. & Lawrence, D.S. (1995). The extraordinary active site substrate specificity of pp60c-Src. A multiple specificity protein kinase. J. Biol. Chem. 270, 5375-5380.
40. Cormack, B.P., Valdivia, R.H. & Falkow, S. (1996). FACS-optimized mutants of the green flurorescent protein (GFP). Gene 173, 33-38.
41. Nicholls, A., Sharp, K.A. & Honig, B. (1991). Protein folding and association: insight from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
42. Hanks, S.K. & Quinn, A.M. (1991). Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38-81.